Literature DB >> 29558798

Efficacious Vaccine against Heroin Contaminated with Fentanyl.

Candy S Hwang1, Lauren C Smith1, Yoshihiro Natori1, Beverly Ellis1, Bin Zhou1, Kim D Janda1.   

Abstract

The sharp increase in overdose deaths involving illicit opioid use has been declared a national crisis in the United States. This growing number of overdose deaths can in part be attributed to the increased frequency of fentanyl contamination in the United States heroin supply. To combat this growing trend, we designed a vaccine containing a mixture of heroin and fentanyl hapten-conjugates as a proof-of-concept immunotherapy targeting a combination of these drugs. Rodents immunized with the admixture vaccine showed drug retention in serum and reduced distribution in the brain after administration of an intravenous bolus of heroin coadministered with fentanyl (10% w/w). Moreover, the admixture vaccine performed as well as or better than individual immunoconjugate vaccines in antinociception behavioral models and recognized six other fentanyl analogues with nanomolar affinity. Taken together, these data highlight the potential of an admixture vaccine against heroin contaminated with fentanyl.

Entities:  

Keywords:  Overdose; fentanyl; hapten; heroin; vaccine

Mesh:

Substances:

Year:  2018        PMID: 29558798      PMCID: PMC6013375          DOI: 10.1021/acschemneuro.8b00079

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  24 in total

1.  A good practice guide to the administration of substances and removal of blood, including routes and volumes.

Authors:  K H Diehl; R Hull; D Morton; R Pfister; Y Rabemampianina; D Smith; J M Vidal; C van de Vorstenbosch
Journal:  J Appl Toxicol       Date:  2001 Jan-Feb       Impact factor: 3.446

Review 2.  Non-analgesic effects of opioids: opioid-induced respiratory depression.

Authors:  Merel Boom; Marieke Niesters; Elise Sarton; Leon Aarts; Terry W Smith; Albert Dahan
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Prevalence and correlates of fentanyl-contaminated heroin exposure among young adults who use prescription opioids non-medically.

Authors:  Alexandria Macmadu; Jennifer J Carroll; Scott E Hadland; Traci C Green; Brandon D L Marshall
Journal:  Addict Behav       Date:  2017-01-06       Impact factor: 3.913

4.  Dynamic vaccine blocks relapse to compulsive intake of heroin.

Authors:  Joel E Schlosburg; Leandro F Vendruscolo; Paul T Bremer; Jonathan W Lockner; Carrie L Wade; Ashlee A K Nunes; G Neil Stowe; Scott Edwards; Kim D Janda; George F Koob
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

5.  Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-Dawley rats.

Authors:  Elizabeth M Peckham; John R Traynor
Journal:  J Pharmacol Exp Ther       Date:  2005-11-16       Impact factor: 4.030

6.  The potential threat of acetyl fentanyl: legal issues, contaminated heroin, and acetyl fentanyl "disguised" as other opioids.

Authors:  John M Stogner
Journal:  Ann Emerg Med       Date:  2014-08-18       Impact factor: 5.721

7.  Fatalities associated with fentanyl and co-administered cocaine or opiates.

Authors:  Mindy J Hull; Matthew Juhascik; Frank Mazur; Mark A Flomenbaum; George S Behonick
Journal:  J Forensic Sci       Date:  2007-10-17       Impact factor: 1.832

8.  Pharmacokinetic correlates of the effects of a heroin vaccine on heroin self-administration in rats.

Authors:  Michael D Raleigh; Paul R Pentel; Mark G LeSage
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

9.  Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches.

Authors:  Matthias Pauthner; Colin Havenar-Daughton; Devin Sok; Joseph P Nkolola; Raiza Bastidas; Archana V Boopathy; Diane G Carnathan; Abishek Chandrashekar; Kimberly M Cirelli; Christopher A Cottrell; Alexey M Eroshkin; Javier Guenaga; Kirti Kaushik; Daniel W Kulp; Jinyan Liu; Laura E McCoy; Aaron L Oom; Gabriel Ozorowski; Kai W Post; Shailendra K Sharma; Jon M Steichen; Steven W de Taeye; Talar Tokatlian; Alba Torrents de la Peña; Salvatore T Butera; Celia C LaBranche; David C Montefiori; Guido Silvestri; Ian A Wilson; Darrell J Irvine; Rogier W Sanders; William R Schief; Andrew B Ward; Richard T Wyatt; Dan H Barouch; Shane Crotty; Dennis R Burton
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

10.  Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors.

Authors:  Ingrid A Binswanger; Carolyn Nowels; Karen F Corsi; Jason Glanz; Jeremy Long; Robert E Booth; John F Steiner
Journal:  Addict Sci Clin Pract       Date:  2012-03-15
View more
  18 in total

1.  A Fentanyl Vaccine Alters Fentanyl Distribution and Protects against Fentanyl-Induced Effects in Mice and Rats.

Authors:  Michael D Raleigh; Federico Baruffaldi; Samantha J Peterson; Morgan Le Naour; Theresa M Harmon; Jennifer R Vigliaturo; Paul R Pentel; Marco Pravetoni
Journal:  J Pharmacol Exp Ther       Date:  2018-11-08       Impact factor: 4.030

Review 2.  Development of vaccines to treat opioid use disorders and reduce incidence of overdose.

Authors:  Marco Pravetoni; Sandra D Comer
Journal:  Neuropharmacology       Date:  2019-06-04       Impact factor: 5.250

3.  Heroin vaccine: Using titer, affinity, and antinociception as metrics when examining sex and strain differences.

Authors:  Candy S Hwang; Lauren C Smith; Cody J Wenthur; Beverly Ellis; Bin Zhou; Kim D Janda
Journal:  Vaccine       Date:  2019-06-05       Impact factor: 3.641

4.  Evaluation of a Dual Fentanyl/Heroin Vaccine on the Antinociceptive and Reinforcing Effects of a Fentanyl/Heroin Mixture in Male and Female Rats.

Authors:  E Andrew Townsend; Paul T Bremer; Kaycee E Faunce; S Stevens Negus; Alaina M Jaster; Hannah L Robinson; Kim D Janda; Matthew L Banks
Journal:  ACS Chem Neurosci       Date:  2020-04-22       Impact factor: 4.418

5.  Effectiveness and selectivity of a heroin conjugate vaccine to attenuate heroin, 6-acetylmorphine, and morphine antinociception in rats: Comparison with naltrexone.

Authors:  Kathryn L Schwienteck; Steven Blake; Paul T Bremer; Justin L Poklis; E Andrew Townsend; S Stevens Negus; Matthew L Banks
Journal:  Drug Alcohol Depend       Date:  2019-08-24       Impact factor: 4.492

6.  Enhancement of a Heroin Vaccine through Hapten Deuteration.

Authors:  Tyson F Belz; Paul T Bremer; Bin Zhou; Beverly Ellis; Lisa M Eubanks; Kim D Janda
Journal:  J Am Chem Soc       Date:  2020-07-27       Impact factor: 15.419

7.  Efficacy and Selectivity of Monovalent and Bivalent Vaccination Strategies to Protect against Exposure to Carfentanil, Fentanyl, and Their Mixtures in Rats.

Authors:  Bethany Crouse; Mariah M Wu; Valeria Gradinati; Andrew J Kassick; Daihyun Song; Rajwana Jahan; Saadyah Averick; Scott Runyon; Sandra D Comer; Marco Pravetoni
Journal:  ACS Pharmacol Transl Sci       Date:  2022-04-20

8.  A fentanyl vaccine constructed upon opsonizing antibodies specific for the Galα1-3Gal epitope.

Authors:  Jiaxing Wang; Beverly Ellis; Bin Zhou; Lisa M Eubanks; Steven Blake; Kim D Janda
Journal:  Chem Commun (Camb)       Date:  2020-05-12       Impact factor: 6.222

9.  Prophylactic vaccination protects against the development of oxycodone self-administration.

Authors:  Jacques D Nguyen; Candy S Hwang; Yanabel Grant; Kim D Janda; Michael A Taffe
Journal:  Neuropharmacology       Date:  2018-06-22       Impact factor: 5.250

10.  Pharmacological mechanisms underlying the efficacy of antibodies generated by a vaccine to treat oxycodone use disorder.

Authors:  M D Raleigh; S J King; F Baruffaldi; A Saykao; F A Hamid; S Winston; M G LeSage; P R Pentel; M Pravetoni
Journal:  Neuropharmacology       Date:  2021-06-11       Impact factor: 5.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.